SK Bioscience’s Acquisition of IDT Biologika

Laura Testa North America Legal Chronicle
Tagged:

Sullivan & Cromwel represented SK Bioscience in the transaction.South Korea-based vaccine developer SK Bioscience has agreed to acquire, through its German subsidiary, a 60 percent majority…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here